Even though we have determined that FANCD2 expression increases with brain tumour grade, it does not indicate if the FA pathway is active in these tumours and could contribute to chemotherapeutic resistance mechanisms [19, 20]. The gene discussed is FANCD2; the disease is brain neoplasm.